TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,136.28−0.11%Brent$109.04−0.16%BTC$81,779.75−0.29%ETH$2,402.99−0.18%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,136.28−0.11%Brent$109.04−0.16%BTC$81,779.75−0.29%ETH$2,402.99−0.18%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Enanta Pharmaceuticals Inc · Overview · TradingHolo

Markets › United States › NAS › ENTA

E

Enanta Pharmaceuticals Inc

NAS:ENTAHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$11.57+4.23%LiveIn session · ≈ AED 42.49 · Market cap $336.98M · Next earnings Mon 16 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+4.2%

1M

−11.3%

3M

−15.7%

6M

−20.8%

1Y

−5.0%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

ENTA +4.23% today

✦ This week in three lines

No written digest yet for ENTA. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR −11.8%

Valuation

P/E vs sector−3.9× vs −1.7×

Price / Book vs sector5.0× vs 2.0×

Price / Sales vs sector4.9× vs 3.9×

Price / Free cash flow vs sector−10.1× vs −1.6×

Forecasts

6 buy0 hold0 sell6 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 85 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All ENTA news →

BUEnanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026

BusinessWire · 7 d ago

TREnanta Pharmaceuticals, Inc. (ENTA) To Present Phase 2 RSV Data at IDWeek 2026

TradingView · 7 d ago

ZAEnanta Pharmaceuticals (ENTA) Reports Q3 Loss, Lags Revenue Estimates

Zacks Investment Research · 70 d ago

Key facts

At close · Mon 19 Oct

Market cap (USD)$336.98M

P/E−3.9×

Dividend yield0.0%

52-week range$10.20 – $17.15

Avg volume (20d)262,740

Shares outstanding29,125,400

Beta0.93

Short interest9.2% of float

Next earningsMon 16 Nov

Radar Score

43

Value41

Quality33

Momentum51

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV),…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.0×−0.68%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

22.8×−0.58%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

118.7×−0.45%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

30.0×+0.49%